Stevenage, United Kingdom

Scott Ellis

This inventor holds 1 USPTO granted patent. Top assignee: Gyroscope Therapeutics Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Scott Ellis. Retrieved from https://idiyas.com/inventor/scott-ellis-rh79q1kk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Scott Ellis and His Patent in Complement-Based Therapeutics.

Introduction

Scott Ellis is an inventor associated with Stevenage, Great Britain, and Gyroscope Therapeutics Limited. His patent work concerns complement factor I and its cofactor, including vectors encoding them and potential therapeutic uses.

Latest Patents

The available information lists 1 patent associated with Scott Ellis: “Complement Factor I and Complement Factor I Cofactor, Vectors Encoding Therefor and Therapeutic Use.” The patent describes subject matter involving complement proteins, genetic vectors, and therapeutic applications.

Career Highlights

Ellis’s listed invention connects his work with research into complement-based therapeutic approaches. The available details identify Gyroscope Therapeutics Limited as his company but do not provide further information about his role or career history.

Collaborations

The listed coworkers associated with Ellis are Anna Dreismann and Josephine Heather Lucienne Joel. The available information does not specify their roles or the nature of their collaboration.

Conclusion

Scott Ellis’s listed patent reflects work on complement factor I, its cofactor, and potential therapeutic uses, in association with Gyroscope Therapeutics Limited.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…